These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19764029)

  • 21. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
    Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
    J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.
    Stankiewicz MJ; Crispino JD
    Blood; 2009 Apr; 113(14):3337-47. PubMed ID: 19168790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.
    Deitz SL; Roper RJ
    Genetics; 2011 Dec; 189(4):1487-95. PubMed ID: 21926299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Brain, Cognitive and Motor Profiles Associated with Partial Trisomy. Modeling Down Syndrome in Mice.
    Roubertoux PL; Baril N; Cau P; Scajola C; Ghata A; Bartoli C; Bourgeois P; Christofaro JD; Tordjman S; Carlier M
    Behav Genet; 2017 May; 47(3):305-322. PubMed ID: 28204906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of craniofacial shape in two mouse models of Down syndrome: Ts65Dn and TcMAC21.
    Singh N; Richtsmeier JT; Reeves RH
    J Anat; 2024 Jun; 244(6):1007-1014. PubMed ID: 38264931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes.
    Zaldumbide A; Carlotti F; Pognonec P; Boulukos KE
    J Immunol; 2002 Nov; 169(9):4873-81. PubMed ID: 12391198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the transcription factor ETS2 in brain of patients with Down syndrome--evidence against the overexpression-gene dosage hypothesis.
    Greber-Platzer S; Schatzmann-Turhani D; Cairns N; Balcz B; Lubec G
    J Neural Transm Suppl; 1999; 57():269-81. PubMed ID: 10666682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.
    Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH
    Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
    Blazek JD; Billingsley CN; Newbauer A; Roper RJ
    Dev Dyn; 2010 Jun; 239(6):1645-53. PubMed ID: 20503361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic up-regulation of sonic hedgehog has little effect on postnatal craniofacial morphology of euploid and trisomic mice.
    Singh N; Dutka T; Reeves RH; Richtsmeier JT
    Dev Dyn; 2016 Feb; 245(2):114-22. PubMed ID: 26509735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ets2 regulates colonic stem cells and sensitivity to tumorigenesis.
    Múnera J; Ceceña G; Jedlicka P; Wankell M; Oshima RG
    Stem Cells; 2011 Mar; 29(3):430-9. PubMed ID: 21425406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
    Lyle R; Gehrig C; Neergaard-Henrichsen C; Deutsch S; Antonarakis SE
    Genome Res; 2004 Jul; 14(7):1268-74. PubMed ID: 15231743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis.
    Wolvetang EJ; Bradfield OM; Hatzistavrou T; Crack PJ; Busciglio J; Kola I; Hertzog PJ
    Neurobiol Dis; 2003 Dec; 14(3):349-56. PubMed ID: 14678752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
    Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
    BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.
    Ge Y; LaFiura KM; Dombkowski AA; Chen Q; Payton SG; Buck SA; Salagrama S; Diakiw AE; Matherly LH; Taub JW
    Leukemia; 2008 Mar; 22(3):521-9. PubMed ID: 18094719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.
    Blazek JD; Gaddy A; Meyer R; Roper RJ; Li J
    Bone; 2011 Feb; 48(2):275-80. PubMed ID: 20870049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The power of comparative and developmental studies for mouse models of Down syndrome.
    Moore CS; Roper RJ
    Mamm Genome; 2007 Jul; 18(6-7):431-43. PubMed ID: 17653795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.
    Moore CS
    Mamm Genome; 2006 Oct; 17(10):1005-12. PubMed ID: 17019652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
    Baxter LL; Moran TH; Richtsmeier JT; Troncoso J; Reeves RH
    Hum Mol Genet; 2000 Jan; 9(2):195-202. PubMed ID: 10607830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.